It is generally considered that mouse embryonic stem cell (ESC) differentiation into blood cells in vitro recapitulates yolk sac (YS) hematopoiesis. As such, similar to YS-derived B-progenitors, we demonstrate here that ESC-derived B-progenitors differentiate into B-1 and marginal zone B cells, but not B-2 cells in immunodeficient mice after transplantation. ESC-derived B-1 cells were maintained in the recipients for more than 6 months, secreting natural IgM antibodies in vivo. Gene expression profiling displayed a close relationship between ESC-and YS-derived B-1 progenitors. Because there are no hematopoietic stem cells (HSCs) detectable in our ESC differentiation culture, successful long-term engraftment of ESC-derived functional B-1 cells supports the presence of HSC-independent B-1 cell development.
INTRODUCTION
Hematopoietic stem cells (HSCs) in the adult bone marrow (BM) provide all types of blood cells throughout life, while also self-renewing to maintain blood homeostasis. Blood/ marrow stem cell transplantation is the most advanced method to cure patients suffering from hematological malignancies and hematopoietic diseases. Consequently, tremendous effort has been dedicated to establishing a system to produce HSCs from pluripotent stem cells (PSCs) such as embryonic stem cells (ESCs) or inducible PSCs. Overexpressing the Hoxb4 gene (Kyba et al., 2002; Wang et al., 2005) , teratoma formation in vivo (Amabile et al., 2013; Suzuki et al., 2013; Tsukada et al., 2017) , and direct reprogramming by introducing multiple transcriptional factors into endothelial cells (ECs) (Sugimura et al., 2017) have demonstrated successful engraftment of PSC-derived hematopoietic cells. Similarly, a recent advance has reported that Hoxb4 expression combined with Delta-like 1 signaling enables mouse ESC-derived hematopoietic progenitor cells (HPCs) to engraft immunodeficient mice with a functional adaptive immune system (Lu et al., 2016) . While these PSC-derived functional HSCs have been reported, low chimerism remains a persistent problem and it is still challenging to produce an HSC in vitro with equivalent properties of in vivo HSCs without gene manipulation. Although conventional ESC differentiation by embryoid body formation or OP9 co-culture produces erythromyeloid, B and T lymphoid cells, no transplantable HSCs are produced (Nakano et al., 1994; Schmitt et al., 2004; Yoshimoto et al., 2009) . In this sense, conventional ESC differentiation reflects HSC-independent hematopoiesis and mimics yolk sac (YS) hematopoiesis before HSC emergence at the later stage (Irion et al., 2010; Lin et al., 2014; Yoshimoto, 2015) .
There are several waves of hematopoiesis in the YS before the detection of the first HSCs at embryonic day 11.5 (E11.5) in the aorta-gonado-mesonephros region that repopulate lethally irradiated adult mice (Hadland and Yoshimoto, 2017; Lin et al., 2014) . These waves include primitive erythroid cells and primitive macrophages at around E7.5 in the YS and definitive (adult) type erythromyeloid progenitors from E8.5 to E9.5 YS. These waves have been considered transient, diminishing after birth. However, recent lineage tracing studies have revealed the presence of tissue-resident macrophages that are produced from early YS precursors independently of HSCs, persist into post-natal life, and are self-maintained without replenishment by BM progenitors (Ginhoux et al., 2010; Gomez Perdiguero et al., 2015; Schulz et al., 2012) . These hematopoietic waves are recently recognized as HSC-independent hematopoiesis. Similarly, we and others have reported T and B lymphoid potential in the YS and/or para-aortic splanchnopleura (P-Sp) region prior to HSC emergence by co-culture with stromal cells (Cumano et al., 1996; Godin et al., 1995; Nishikawa et al., 1998; Yoshimoto et al., 2011 Yoshimoto et al., , 2012 . However, it is still controversial whether these T and B cells are produced independently of HSCs because the co-culture system also yields transplantable hematopoietic progenitor/ stem cells from as early as E8.0 embryos, which makes the origin of early lymphoid cells unclear, whether it is derived from HSC-independent or -dependent precursors (Cumano et al., 2001; Matsuoka et al., 2001 
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+ B220 + B-progenitors were obtained at 10-14 days after initiating the co-culture, those B-progenitors were transplanted into sublethally irradiated NSG neonates or a subject of RNA sequencing.
We previously reported that the earliest B cells produced in vitro from YS/P-Sp at pre-HSC stages are B-1 cells (Yoshimoto et al., 2011) . B-1 cells are unique innate-like B cells, residing mainly in the pleural and peritoneal cavities, and are segregated from conventional adaptive immune B-2 cells (Baumgarth, 2017 (Ghosn et al., 2012; Hardy and Hayakawa, 1991) and a conditional Rag2 knockout mouse model (Hao and Rajewsky, 2001) . Our report demonstrating the presence of B-1-specific progenitors in the FL in HSC-deficient embryos supports the concept of HSC-independent lymphopoiesis (Kobayashi et al., 2014) . In addition, the existence of HSC-independent T lymphopoiesis has been recently reported in a zebrafish model (Tian et al., 2017 Table S1 ). ESC-derived B-2 follicular B (FO) cells were not detected, again, similar to the results from YSderived B cell engraftment (Figures 1G, 1H, and 2B) . No thymus was detected in the recipient mice and no myeloid or T cells were detected in the spleen and BM ( Figure S1 ). Table S1 . (H) Summary for differentiation capacity of progenitors that are derived from ESC, YS, FL, and BM. P-, peritoneal; S-, spleen. ***p < 0.0001, **p < 0.01.
Thus, only B-1 and MZ B cells were differentiated from ESC-derived B-progenitors in the recipient mice.
ESC-Derived B Cells Display Long-Term Engraftment in the Peritoneal Cavity and Spleen
An important characteristic of B-1 cells is self-replenishing ability. We detected ESC-derived B-1 cell engraftment more than 6 months in 10 out of 23 transplanted mice without engraftment of other lineages ( Figures 1C and 3A) . ESCderived B-1 and MZ B cells were also detected in the recipient spleen (Figures 1F, 1G, and 3A) . Fat-associated lymphoid clusters (FALCs) have recently been reported as a niche for B-1 cells (Benezech et al., 2015; Moro et al., 2010) . Fat tissues were isolated from the recipient peritoneal cavity and stained with anti-IgM antibodies. While non-transplanted NSG mice did not show any IgM + cells, transplanted NSG mice showed a few, but large, IgM + clusters in the peritoneal fat tissues ( Figure 3B ). We also examined ESC-derived IgM + cells in the recipient spleen.
IgM + IgD À B-1/MZ B cells were confirmed as clusters in the recipient spleen ( Figure 3C ) although a normal follicular structure was not seen due to lack of T and B-2 cells. Thus, ESC-derived B-progenitors differentiate into B-1 cells in the peritoneal cavity and MZ B cells in the spleen in the recipient mice and are maintained for more than 6 months. (C) Immunostaining of spleen in non-transplanted B6 mice (control) and the recipient mice after PC stimulation (n = 3). Green, anti-IgD antibody; red, anti-IgM antibody; blue, DAPI. Scale bar, 100 mm. (D) ELISpot assays against anti-PC IgM using 1,000 ESC-derived B-1 cells harvested from the peritoneal cavity of transplanted mice, and 1,000 B-1 and B-2 cells harvested from the B6 peritoneal cavity (n = 3 for each group). (E) Concentrations of serum IgM from non-transplanted NSG with or without PC stimulation, NSG mice transplanted with ESC-or YS-derived B-progenitors, and non-treated B6 mice are depicted. All transplanted mice were stimulated with PC before collecting the serum (n = 3 for each group). **p < 0.01.
( Figure 3D ). Phosphorylcholine was injected into the mice transplanted with ESC-derived B cells and the serum IgM was measured by enzyme-linked immunosorbent assay (ELISA) assays ( Figure 3E ). The control mice transplanted with YS-derived B cells displayed similar levels of serum IgM to non-transplanted C57BL/6 mice. The recipient NSG mice transplanted with ESC-derived B cells showed elevated IgM levels compared with non-transplanted NSG mice, although less than non-transplanted C57BL/6 serum IgM or YS-derived serum IgM. The difference in IgM level between mice transplanted with ESC-and YS-derived B cells might depend on the cell numbers engrafted in the host mice. Thus, ESC-derived B-1 cells are functional IgMsecreting cells in vivo.
Gene Expression Profile of ESC-Derived B-Progenitors Is Similar to that of YS-and FL-Derived B-1 Progenitors
We compared gene expression profiles among ESC-, YS-, and FL-derived B-1 progenitors and BM-derived B-2 progenitors to evaluate molecular similarities ( Figure 4A ). Principalcomponent analysis showed that ESC-derived B-progenitors are molecularly closer to YS-and FL-derived B-1 progenitors rather than BM-derived B-2 progenitors, as expected (Figure 4B) . However, there were 1,759 genes differentially expressed between ESC-derived and YS-derived B-1 progenitors (p < 0.05, false discovery rate [FDR] < 0.05, >2-fold). Among them, 715 genes were upregulated and 1,044 genes were downregulated in ESC-derived B-progenitors compared with YS-derived B-progenitors. On the other hand, 4,805 genes were differentially expressed between ESC-and BM-derived B-progenitors (2,479 genes were upregulated, and 2,326 genes were downregulated in ESCderived B-progenitors, p < 0.05, FDR < 0.05, >2-fold).
Careful evaluation of the transcription factors important for B cell development revealed that ESC-derived B-progenitors were similar to those of YS-or FL-derived B-progenitors ( Figure 4C ). Since FL-derived B-progenitors include some cells with B-2 potential, expression was at times similar to BM-derived B cells, depending on the genes. Lmo2, Spi1 (PU.1), Pax5, Ebf1, and Ikzf1 were expressed higher in BM-derived B-progenitors than ESC-, YS-, and FL-derived B-1 progenitors, while Rag2 and Bcl11a were expressed higher in the ESC-, YS-, and FL-derived B-progenitors ( Figure 4C ). Expression patterns of chemokine receptors showed a distinct difference between YS/FL-derived B-1 progenitors and BM-derived B-2 progenitors, and those chemokine receptors appeared to be silent in ESC-derived B-progenitors ( Figure 4D ). Among them, Ccr7 and Cxcr5 were expressed differently between ESC-derived and YS/ FL-derived B-progenitors. CXCR5 is an important homing receptor for B-1 cells that promotes retention in the peritoneal cavity (Hopken et al., 2004) , thus this difference could account for the lower efficiency of ESC-derived B cell engraftment in the recipient mice. Expression of some cytokine receptors was also reduced in the ESC-derived B-progenitors ( Figure 4E ). We also looked into genes involved in epigenetic modification ( Figure 4F ). We confirmed that ESC-derived B-progenitors showed lower expression of Bmi1 and Rnf2 (Ring1B), an important component of polycomb repressive complex 1. We performed gene ontogeny (GO) enrichment analysis between ESC-and YS-derived B-progenitors and identified the top 10 categories of upregulated genes in YS-derived B-progenitors ( Figure 4G ) and in ESC-progenitors ( Figure 4H ). While MHC protein complex and interferon-g signaling pathways were upregulated in the YS-derived B-1 progenitors, some mesodermal developmental signatures were still upregulated in the ESC-derived B-1 progenitors. Taken together, ESC-derived B-1 progenitors may not be fully developed, although B cell transcription factors are similar between YS-and ESC-derived B-1 progenitors. Nonetheless, engrafted ESC-derived B-1 cells were immunologically functional; thus, some ESC-derived B-progenitors might be selected in vivo or these differences may reflect the lack of B-1a cells from ESC-derived B-1 progenitors.
Bmi1 Overexpression Improved ESC-Derived B-1 Cell Engraftment Since Bmi1 expression was reduced in ESC-derived B-progenitors ( Figure 4F ) and Bmi1 overexpression is reported to increase the self-renewal capacity of HSCs and self-renewing YS-derived erythroid progenitor cells (Iwama et al., 2004; Kim et al., 2015) , we hypothesized that overexpression of Bmi1 might improve ESC-derived B cell engraftment. qPCR showed less Bmi1 expression in ESC-derived B-progenitors compared with YS-derived B-progenitors ( Figure 5A ). Therefore, we overexpressed Bmi1 in ESCs by retrovirus, differentiated them into B-progenitors on OP9, and transplanted AA4.1 + CD19 + B220 + B-progenitors into sublethally irradiated NSG neonates as described above. Elevated Bmi1 expression was confirmed by qPCR ( Figure 5A ). In the recipient peritoneal cavity, Bmi1-overexpressing B cells demonstrated significantly better engraftment at 4-5 weeks ( Figure 5B , n = 8, average donor 26.6% ± 21.3%, p = 0.01), and at 4 months after transplantation ( Figure 5C , n = 7, average donor 21.4% ± 16%, p < 0.05) compared to parent ESC-derived B cells (n = 5, 0.73% ± 0.58% at 5 weeks, n = 3, 4.3% ± 2.1% at 4 months). Of note, despite improved engraftment, ESC-derived B-1a cells were not detected ( Figure 5D ). We also examined CXCR5 expression in differentiated ESC-derived IgM + cells on OP9 culture because CXCR5
is an essential chemokine receptor expressed in the peritoneal B-1 cells and Cxcr5 deletion induced B-1 cell loss in the peritoneal cavity (Hopken et al., 2004) . We confirmed CXCR5 expression in B-1 cells of non-transplanted 
C-F) Heatmap analysis among ESC-, YS-, FL-, and BM-derived B-progenitors for B cell-related transcription factors (C), chemokine receptors (D), cytokine receptors (E), and epigenetic regulatory genes (F). (G and H) The top 10 categories of upregulated genes in YS-derived B-progenitors (G) and ESC-progenitors (H) between these two populations by gene ontology enrichment analysis are listed. B-pro, B-progenitors
C57BL/6 mice and ESC-derived B-1 cells engrafted in NSG mice ( Figure 5E ). However, in in vitro differentiation on OP9, IgM + cells from parent ESCs was not efficiently produced and showed less CXCR5 expression, while YS and Bmi1-ESCs differentiated into CXCR5-expressing IgM + cells at 3 weeks after differentiation ( Figure 5F ). These results suggested that the differentiation efficiency into CXCR5 + IgM + cells may be a key for ESC-derived B-progenitors to engraft in the recipient peritoneal cavity. Further studies have to be done to enhance the engraftment of ESC-derived B-progenitors.
DISCUSSION
We demonstrated that all B-progenitors produced from mouse ESCs differentiate into only B-1 and MZ B cells in recipient mice, similar to YS-derived B-progenitors (Figure 1H) . Although ESC-derived B-1 cells are functional in natural antibody secretion and self-replenishing ability, they differentiate to mostly B-1b cells, not to B-1a cells, while almost half of YS-derived B-progenitors differentiate into B-1a cells in vivo ( Figure 1E ) (Yoshimoto et al., 2011 PSC-derived HPC engraftment in the recipient BM and spleen, detectable by PCR (Yoshimoto et al., 2009 ). Pearson et al. (2015) have reported better engraftment of ESCderived hematopoietic cells after serum-free differentiation culture. However, despite T cell differentiation potential in vitro, T cell engraftment was not shown and B cell engraftment was limited to the spleen. They indicated that the engrafted B cells in the recipient spleen were not B-1 cells because they lacked expression of CD5 and CD11b. However, CD11b is only expressed in peritoneal B-1 cells, not in splenic B-1 cells. Furthermore, CD5 expression is limited to B-1a cells. Since they did not show any B cell engraftment in the peripheral blood (which is considered to represent the B-2 cell population), it is very likely that the ESC-derived B cells engrafted in the recipient spleen were MZ or B-1 cells, consistent with our results. Lu et al. (2016) have reported repopulation of functional adaptive immune T and B cells by engineered mouse ESCs, which was produced by inducing Notch signaling and Hoxb4 overexpression. In their control, conventional ESC differentiation on OP9 (without Notch signaling) produced only B-1b cells, not B-2 cells, supporting our results. Notch signaling seems to have induced functional adaptive B-2 cells via HSCs in their system, although their secondary transplantation of engineered HSCs displayed T cell dominant engraftment. This result suggests that sustained B-2 potential always accompanies HSC potential, different from B-1 cells that can be produced by early HSC-independent progenitors. Although lymphoid potential has been used as an indicator of ''definitive hematopoiesis'' in the early mouse embryo or ESC differentiation system (Cumano et al., 1996; Kennedy et al., 2012) , it is important to reconsider the definition of definitive hematopoiesis, because some T and B-1 lymphoid progenitors can be produced in the absence of HSCs (Chen et al., 2011; Kobayashi et al., 2014; Tian et al., 2017) . In this sense, sustained B-2 cell production may be a more accurate indicator of HSC activity. Therefore, understanding how B-2 potential is obtained in ESC-derived HPCs would represent an important area of future investigation.
RNA-seq results also support the similarity between ESCand YS-derived B-1 progenitors. Bmi1 expression, known as an important gene for self-renewal ability in stem cells, was reduced in ESC-derived B cells compared with YS-derived B cells, and Bmi1 overexpression improved the engraftment of ESC-derived B cells in the recipient mice. Our result is similar to the report that inducing Bmi1 into adult BM erythroblasts enhanced self-renewal ability extensively (Kim et al., 2015) . Thus, Bmi1 may also play a role in the self-renewal ability of B-1 cells.
Of note, there was a variation of engraftment efficiency among B cells derived from regular ESCs ( Figures 1C, 5B , and 5C ES total). Since B-progenitors differentiate into mature IgM + cells by interacting stromal cells and cytokines in the BM and spleen, the differentiation capacity and characteristics of each ESC line could be important factors for the engraftment, and Bmi1-overexpression may have helped this differentiation process as was seen in vitro experiments ( Figure 5F ). The clinical importance of human B-1 cells has attracted attention based on the methods to isolate the human counterpart of mouse B-1 cells . Since BM HSCs do not reconstitute B-1a cells, patients after BM transplantation may lack B-1 cells if human B-1 cells have similar characteristics with mouse B-1 cells. Indeed, it has been reported that patients who develop graft versus host disease following stem cell transplantation are at high risk for developing sepsis from encapsulated bacteria, associated with deficiency of human B-1-like cells that normally produce natural antibodies to these bacteria (Moins-Teisserenc et al., 2013) . Therefore, PSC-derived B-1 cells could theoretically be an important source of cell therapy for these patients in the future.
In summary, our data indicate the successful engraftment of ESC-derived functional B-1 cells without gene modifications, supporting the presence of HSC-independent lymphopoiesis and suggesting possible unique applications for cell therapy in the future. 
EXPERIMENTAL PROCEDURES

Flow Cytometry and Magnetic-Activated Cell Sorting
Different fluorochrome-conjugated following antibodies (all purchased from eBioscience) were used for the flow cytometry analysis and sorting: anti-mouse Flk1 (clone Avas12a1), CD144 (11D4.1), CD19 (eBio1D3), B220 (RA3-6B2), AA4.1 (AA4.1), IgM (11/41), CD23 (B3B4), CD11b (M1/70), 3), CD45.1 (A20), CD45.2 (104), CD44 (1M7), CD41 (eBioMWReg30), CD25 (PC61), Thy1.2 (53-2.1), CD3 (145-2C11). Propidium iodide (PI) (Sigma-Aldrich) was used for live cell gating. Stained cells were analyzed or sorted on LSRII, FACSCantoII, or FACSAria instrument (BD). Flow cytometry data were analyzed in FlowJo software.
For magnetic-activated cell sorting, CD19 + cells were separated following the manufacturer's instructions using anti-mouse CD19 antibody and anti-Rat IgG MicroBeads (Miltenyi Biotech). The purity of sorted CD19 + cells was >95%, confirmed by flow cytometry. 
OP9 Cells and ESCs
OP9 stromal cells were provided by Dr. Toru Nakano at Osaka University. ESC lines such as D3, D4, and E14 were kindly provided by Dr. Toshio Heike (retired from Kyoto University). OP9 and ESCs were maintained as described previously (Yoshimoto et al., 2009 ).
B Cell Differentiation and Transplantation
B cells were differentiated from ESCs as described previously (Yoshimoto et al., 2009 ). In brief, day 4 Flk1 + or day 5 VC + cells of ESC differentiation culture were sorted and re-plated on fresh OP9 monolayers in 6-well culture plates at a density of 3,000-5,000 cells/well and were cultured for an additional 10-14 days in induction medium with 10 ng/mL interleukin-7 (IL-7) and Flt3-ligand (PeproTech). B cells were differentiated from E9.5 YS as described previously (Yoshimoto et al., 2011) .
To obtain FL-and BM-derived B cells, CD19 + B-progenitors from E14.5 FL or CD19 + B220 + B-progenitors from adult BM were sorted and cultured on OP9 for 6 days with 10 ng/mL IL-7 and Flt3-ligand. After cobblestone-like B cell colonies were formed in the culture, the cells were collected. AA4.1 + CD19 + B220 + cells were then sorted by FACSAria (Becton Dickinson) and were used for downstream experiments or kept in liquid nitrogen as cell pellets for RNA-seq. For cell transplantation, donor cells were re-suspended in 25 mL PBS and were injected into the peritoneal cavity of sublethally (150 rad) irradiated NSG neonates (1-3 days old). At different time points after transplantation, the peritoneal, spleen or BM cells were collected and donor cell types were examined by flow cytometry.
Images and Confocal Microscopy
Pictures of cell culture were taken on a Leica DM IL microscope with a SPOT RT3 camera (Spot Imaging). For confocal microscopy images of FALCs, recipient NSG were euthanized, and omentum and mesenteric fat tissues were dissected. The samples were prepared as described previously (Benezech et al., 2015) and stained with 1:200 Alexa Fluor 555-conjugated anti-mouse IgM antibody (SouthernBiotech). Confocal images were taken using an Olympus II microscope with UApoN340 203/0.7W objectives (Olympus). ImageJ software was used to adjust and output the images.
Natural Antigen Immunization and ELISA
To measure the serum IgM concentration after natural antigen challenge, mice were immunized by intraperitoneal injection of 200 mL 0.25 mg/mL phosphorylcholine conjugated to keyhole limpet hemocyanin (PC-KLH). After 10 days, the mice were euthanized and blood serum was used for IgM ELISA assay using eBioscience Mouse IgM ELISA Ready-SET-Go! Kit according to the manufacturer's instructions.
ELISpot
ELISpot assays were performed as described previously (Kobayashi et al., 2014) . In brief, B cells were sorted from the peritoneal cavity or spleen of recipient or control animals by FACSAria (BD Bioscience). The cells were re-suspended in RPMI 1640 medium with 10% fetal bovine serum, 5 3 10 À5 M b-mercaptoethanol, and 10 ng/mL IL-5 (PeproTech) and plated on 96-well plates that were pre-coated with 10 mg/mL PC-KLH. After 24 h incubation, the cells were collected and re-plated into each well of ELISpot Multiscreen HTS Filter Plates (Millipore) pre-coated with 10 mg/mL anti-mouse IgM antibody (eBioscience). After 24 h, the wells were incubated with 1:2,000 alkaline phosphate-conjugated goat anti-IgM detection antibody (SouthernBiotech) and the spots were visualized by BCIP/NBT-plus substrate (Mabtech). Photos of spots were taken using a Zeiss Stemi SV 11 microscope with Zeiss Axiocam Mrc5 camera.
RNA-Seq
Cell pellets of sorted B-progenitors derived from ESCs, E9.5 YS, E14.5 FL, and adult BM were snap-frozen in liquid nitrogen and stored at À80 C before RNA isolation. RNA was isolated using RNeasy
MicroMini Kit (QIAGEN) and submitted to the Center for Medical Genomics at IUSM for the RNA-seq. Total RNA was first evaluated for its quantity and quality, using an Agilent Bioanalyzer. Starting amount of total RNA ranged from 200 to 1,000 ng for library preparation. Ribosomal RNA was first removed from total RNA using a standard protocol for the Ribo-Zero Magnetic Gold Kit (Epicentre, cat. no. MRZG12324/RZG1224 
Bioinformatic Analysis
RNA-seq was carried out using a standard RNA-seq protocol by Ion Proton technology in the Center for Medical Genomics, Indiana University. The sequencing data were mapped to the Mus musculus mm10 reference genome using RNA-seq aligner STAR (v.2.4.2) (Dobin et al., 2013) . The gene-based expression levels were quantified with featureCounts (subread v.1.5.0) (Liao et al., 2014) applying parameters ''-s 1 -Q 10.'' Read counts were normalized to the total number of sequencing reads falling into annotated gene regions in each sample, and further scaled based on a trimmed mean of log transformed counts per million (CPM) value to correct for the variability of RNA composition in each sample. The genes with greater than one read per million mappable reads (CPM > 1) in at least four samples were kept for gene differential expression analysis with the R/Bioconductor package edgeR (Robinson et al., 2010) . Benjamini and Hochberg's algorithm was used to control the FDR. Gene set enrichment analysis was performed on the C2 curated gene sets and the C5 GO gene sets of the Molecular Signature Database using the function CAMERA in edgeR (Robinson et al., 2010) .
Overexpressing Bmi1 in ESCs
Mouse Bmi1 cDNA was cloned into pMIPTcG (pMIEG3-IRES-puroR/ T2A/GFP) and the sequence was confirmed. Subsequently, virus was produced with Phoenix-Eco producer line by a standard method (Kobayashi et al., 2017) . ESCs were infected with pMIPTcG-Mock or -Bmi1 virus, followed by selection with puromycin.
Statistics
The unpaired, two-tailed Student's t test was used for statistical analysis in this study.
RNA-Seq Accession Number
RNA-seq data are available in the GEO under accession number, GSE123809.
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